ZBH analyst estimates
Zimmer Biomet (ZBH) analyst ratings, the average price target and its range, and every firm's latest call.
ZBH analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Aug 10, 2026 | Canaccord Genuity | Zimmer Biomet price target raised to $100 from $83 at Canaccord | $100.00 |
| Aug 6, 2026 | RBC Capital | Zimmer Biomet price target raised to $110 from $101 at RBC Capital | $110.00 |
| Aug 6, 2026 | BMO Capital | Zimmer Biomet price target raised to $96 from $95 at BMO Capital | $96.00 |
| Aug 6, 2026 | Bernstein | Zimmer Biomet price target raised to $93 from $91 at Bernstein | $93.00 |
| Aug 6, 2026 | UBS | Zimmer Biomet price target raised to $120 from $115 at UBS | $120.00 |
| Aug 6, 2026 | Robert W. Baird | Zimmer Biomet price target raised to $104 from $92 at Baird | $104.00 |
| Aug 6, 2026 | Truist Financial | Zimmer Biomet price target raised to $106 from $92 at Truist | $106.00 |
| Jul 28, 2026 | UBS | Zimmer Biomet upgraded to Buy from Sell at UBS | $115.00 |
| Jul 8, 2026 | BMO Capital | Zimmer Biomet initiated with a Market Perform at BMO Capital | $95.00 |
| Apr 29, 2026 | Barclays | Zimmer Biomet price target lowered to $94 from $100 at Barclays | $94.00 |
| Apr 29, 2026 | Robert W. Baird | Zimmer Biomet price target lowered to $92 from $100 at Baird | $92.00 |
| Apr 29, 2026 | Stifel Nicolaus | Zimmer Biomet price target lowered to $105 from $110 at Stifel | $105.00 |
| Apr 29, 2026 | Canaccord Genuity | Zimmer Biomet price target lowered to $83 from $93 at Canaccord | $83.00 |
| Apr 29, 2026 | Truist Financial | Zimmer Biomet price target lowered to $92 from $98 at Truist | $92.00 |
| Feb 12, 2026 | Barclays | Zimmer Biomet price target lowered to $100 from $104 at Barclays | $100.00 |
- 18 firms rate ZBH: 5 buy, 12 hold, 1 sell.
- The average price target is $104.14 from 7 analysts, from $93.00 to $120.00.
Updated 2026-11-03 00:01 UTC